Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • ramiro2k
    Member
    • Mar 2012
    • 12

    #1

    Simple effects in DESeq2

    Hello, this is probably a very simple point, but I want to make sure I understand this. In the DESeq2 ?results document it lists the following example (and comment):

    ## Example 2: two conditions, two genotypes, with an interaction term

    dds <- makeExampleDESeqDataSet(n=100,m=12)
    dds$genotype <- factor(rep(rep(c("I","II"),each=3),2))
    design(dds) <- ~ genotype + condition + genotype:condition
    dds <- DESeq(dds)
    resultsNames(dds)

    # Note: design with interactions terms by default have betaPrior=FALSE

    # the condition effect for genotype I (the main effect)
    results(dds, contrast=c("condition","B","A"))


    QUESTION:
    1. shouldn't what is called "the condition effect for genotype I (the main effect)" be called the simple effect for condition on genotype I?? The term "main effect" I am not sure is appropriate here as we are not averaging over all genotypes.
    2. If (1) is correct, how would one specify on DESeq2 a real main effect of B vs A averaged over all genotypes?

    Thank you,
    Ramiro
    Last edited by ramiro2k; 05-16-2017, 08:42 AM.

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
25 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
20 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Working...